We are live on
!
Find out more
AAP
Ardsley Advisory Partners Portfolio holdings
AUM
$960M
1-Year Est. Return
207.76%
This Fund
S&P 500
This Quarter
Est. Return
+14.96%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$627M
AUM Growth
+$181M
(+41%)
Cap. Flow
+$49M
Cap. Flow
% of AUM
7.81%
Top 10 Holdings %
Top 10 Hldgs %
46.99%
Holding
210
New
76
Increased
33
Reduced
30
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Guardant Health
GH
|
+$17.7M |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$9.51M |
| 3 |
Twilio
TWLO
|
+$7.81M |
| 4 |
STKL
SunOpta
STKL
|
+$7.64M |
| 5 |
LHCG
LHC Group LLC
LHCG
|
+$7.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$10.6M |
| 2 |
Medifast
MED
|
+$9.84M |
| 3 |
AY
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
|
+$9M |
| 4 |
First Solar
FSLR
|
+$8.39M |
| 5 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$7.43M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.92% |
| 2 | Miscellaneous | 24.45% |
| 3 | Healthcare | 16.32% |
| 4 | Industrials | 12.05% |
| 5 | Consumer Discretionary | 6.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
PUT
Broadcom
AVGO
$1.66T
| $948K | 0.15% |
+30,000
| New | +$911K |
|
77
Novartis
NVS
$268B
| $947K | 0.15% |
+10,000
| New | +$897K |
|
78
PUT
Ciena
CIEN
$48.8B
| $854K | 0.14% |
20,000
+6,000
| +43% | +$229K |
|
79
BlackLine
BL
$1.66B
| $799K | 0.13% |
+15,500
| New | +$774K |
|
80
Western Digital
WDC
$153B
| $793K | 0.13% |
+16,538
| New | +$690K |
|
|
AMED
81
DELISTED
Amedisys
AMED
| $751K | 0.12% |
+4,500
| New | +$669K |
|
|
VTNR
82
DELISTED
Vertex Energy, Inc
VTNR
| $740K | 0.12% |
484,306
-20,000
| -4% | -$26.6K |
|
83
Tandem Diabetes Care
TNDM
$1.2B
| $715K | 0.11% |
12,000
+6,000
| +100% | +$370K |
|
84
NVIDIA
NVDA
$5.3T
| $706K | 0.11% |
+120,000
| New | +$624K |
|
|
CRON
85
Cronos Group
CRON
$1.24B
| $703K | 0.11% |
91,677
| – | – |
|
86
TSMC
TSM
$2.23T
| $697K | 0.11% |
+12,000
| New | +$636K |
|
87
CALL
Encompass Health
EHC
$12.1B
| $693K | 0.11% |
+12,570
| New | +$682K |
|
88
Workday
WDAY
$48B
| $658K | 0.11% |
+4,000
| New | +$664K |
|
89
Vertex Pharmaceuticals
VRTX
$131B
| $657K | 0.1% |
3,000
-2,000
| -40% | -$405K |
|
90
Abbott
ABT
$177B
| $651K | 0.1% |
7,500
-10,000
| -57% | -$838K |
|
91
Micron Technology
MU
$1.1T
| $645K | 0.1% |
+12,000
| New | +$573K |
|
92
NXP Semiconductors
NXPI
$57.5B
| $636K | 0.1% |
+5,000
| New | +$580K |
|
|
THS
93
DELISTED
Treehouse Foods
THS
| $607K | 0.1% |
+12,500
| New | +$640K |
|
|
DERM
94
DELISTED
Dermira, Inc.
DERM
| $606K | 0.1% |
+40,000
| New | +$345K |
|
95
PUT
Skyworks Solutions
SWKS
$13.7B
| $604K | 0.1% |
+5,000
| New | +$491K |
|
96
Zimmer Biomet
ZBH
$18B
| $599K | 0.1% |
4,120
-4,120
| -50% | -$569K |
|
97
FIVE9
FIVN
$2.58B
| $590K | 0.09% |
9,000
+1,500
| +20% | +$91.8K |
|
98
Deutsche Bank
DB
$73.4B
| $584K | 0.09% |
+75,000
| New | +$563K |
|
99
Medtronic
MDT
$119B
| $567K | 0.09% |
5,000
-3,000
| -38% | -$329K |
|
100
Arcadia Biosciences
RKDA
$1.15M
| $548K | 0.09% |
+2,503
| New | +$502K |
|
Similar funds
RAM
JWBC
PL
SCM
LGP
WI
LAM
ACP
Ardsley Advisory Partners's Q4 2019 Portfolio in Review
As of Q4 2019, Ardsley Advisory Partners held 210 positions worth $627M, up 41% from $446M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Ardsley Advisory Partners deployed $49M of net new capital in Q4 2019, opening 76 new positions and adding to 33 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 110,000 shares worth $10.5M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 29% a quarter earlier, followed by Miscellaneous and Healthcare.
On the sell side, the largest reduction was Walt Disney, an estimated $10.6M trimmed.
- Ardsley Advisory Partners's largest Q4 2019 buy was State Street SPDR S&P Biotech ETF: 110,000 shares worth $10.5M.
- Ardsley Advisory Partners added most to Guardant Health in Q4 2019, an estimated $17.7M increase.
- Ardsley Advisory Partners's biggest Q4 2019 reduction was Walt Disney, cutting an estimated $10.6M.
- Ardsley Advisory Partners fully exited Medifast in Q4 2019, selling an estimated $9.84M.
- Ardsley Advisory Partners's ten largest holdings make up 47% of its $627M portfolio in Q4 2019.
- Ardsley Advisory Partners opened 76 new positions and closed 60 in Q4 2019.
- Ardsley Advisory Partners's portfolio value rose 41% quarter-over-quarter to $627M.
Based on Ardsley Advisory Partners's 13F filing for Q4 2019, filed 14 Feb 2020.